See also this year's filing and all EDGAR filings for this company.
PDF Report 0001828185_2022_Barinthus_Biotherapeutics_plc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Calc2)': 4, '00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS': 16}} |
Graph
Absolute values for 0001828185, Barinthus Biotherapeutics plc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 226,765,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 44,060,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,829,000 |
| 3 | remainder_Assets | 8,061,000 |
| 4 | LiabilitiesCurrent | 11,158,000 |
| 5 | LiabilitiesNoncurrent | 6,540,000 |
| 6 | remainder_Liabilities | 10,455,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 25,118,000 |
| 9 | ResearchAndDevelopmentExpense | 20,371,000 |
| 10 | remainder_Expenses | -28,000 |
| 11 | remainder_Revenues | 268,000 |
| 12 | remainder_NetIncome | -5,919,000 |
| 13 | remainder_ComprehensiveNetIncome | -6,998,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 280,715,000 |
| 1 | Liabilities | 28,153,000 |
| 2 | Expenses | 45,461,000 |
| 3 | Revenues | 268,000 |
| 4 | StockholdersEquity | 252,562,000 |
| 5 | NetIncome | -51,112,000 |
| 6 | ComprehensiveNetIncome | -54,611,000 |
| 7 | BaseVar | 183,757,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.21 |
| 9 | EconomicCapitalRatio | 3.83 |
Edgar->Model Mapping
Feature Distribution
